Stocktoria
Eloxx Pharmaceuticals, Inc. ELOX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2012-11-23
Eloxx Pharmaceuticals, Inc. statistics & valuation
Market cap$505,139
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | -38.8% | — | — | — |
| Net margin | — | -49.4% | — | — | — |
| Return on assets | -113.8% | -105.6% | -996.1% | -170.7% | -147.8% |
| Return on equity | 50.3% | 12.9% | 75.5% | 338.3% | -298.1% |
| Debt / equity | -0.08× | -0.00× | -0.07× | -1.10× | 0.54× |
| Current ratio | 0.31 | 0.11 | 0.07 | 0.87 | 4.37 |
| Revenue growth | -100.0% | — | — | — | — |
Source: SEC EDGAR filings · CIK 0001035354 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.